{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:40:44Z","timestamp":1792662044354,"version":"4.5.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012665","name":"ICES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025092","name":"Ontario Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The effectiveness and safety of recombinant tissue-plasminogen activator (rt-PA; alteplase) for acute ischemic stroke in patients with low estimated glomerular filtration rate (eGFR) are uncertain. We evaluated whether the risks and benefits of rt-PA versus no rt-PA vary by eGFR category.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a population-based cohort study of 4632 rt-PA-eligible adults with acute ischemic stroke and a recorded eGFR in Ontario, Canada (2002\u20132013). Propensity score overlap weighting was used to balance treated and untreated patients. Primary outcomes were transformation to intracranial hemorrhage (ICH) and functional independence at hospital discharge. Secondary outcomes were in-hospital and 1-year mortality. Analyses were stratified by eGFR category (ml\/min\/ 1.73 m2): \u226560, 30\u201359, and\u00a0&amp;lt;30 or receiving maintenance dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After weighting, 1354 patients were included. For eGFR\u00a0\u226560, ICH occurred in 58\/402 (14.4%) with rt-PA and 23\/402 (5.7%) without rt-PA; weighted relative risk (RRw) 2.56 (99% CI, 1.77\u20133.69). For eGFR 30\u201359, ICH was 36\/246 (14.6%) versus 10\/246 (4.0%); RRw 3.67 (99% CI, 2.17\u20136.20). For eGFR\u00a0&amp;lt;30 or maintenance dialysis, event counts were small, preventing reliable estimation. rt-PA was associated with greater discharge independence across all eGFR categories. In-hospital mortality did not differ by treatment within eGFR categories. One-year mortality was lower with rt-PA for eGFR\u00a0\u226560, with comparable point estimates for eGFR 30\u201359 and\u00a0&amp;lt;30 or maintenance dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with low kidney function, rt-PA increases ICH risk but improves functional outcomes. The balance of risks and benefits appears broadly consistent across eGFR categories.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfag222","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:33:32Z","timestamp":1790681612000},"source":"Crossref","is-referenced-by-count":0,"title":["Intravenous alteplase for acute ischemic stroke across kidney function: a population-based cohort study"],"prefix":"10.1093","author":[{"given":"Sarah E","family":"Bota","sequence":"first","affiliation":[{"name":"Department of Epidemiology & Biostatistics, Western University , London, Ontario ,","place":["Canada"]},{"name":"ICES , Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Dixon","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Biostatistics, Western University , London, Ontario ,","place":["Canada"]},{"name":"ICES , Ontario ,","place":["Canada"]},{"name":"London Health Sciences Centre Research Institute , London, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira K","family":"Kapral","sequence":"additional","affiliation":[{"name":"ICES , Ontario ,","place":["Canada"]},{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto , Toronto ,","place":["Canada"]},{"name":"Division of General Internal Medicine, Department of Medicine, University of Toronto , Toronto, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hackam","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Western University , London, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish M","family":"Sood","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M","family":"Sontrop","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Biostatistics, Western University , London, Ontario ,","place":["Canada"]},{"name":"London Health Sciences Centre Research Institute , London, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Biostatistics, Western University , London, Ontario ,","place":["Canada"]},{"name":"ICES , Ontario ,","place":["Canada"]},{"name":"London Health Sciences Centre Research Institute , London, Ontario ,","place":["Canada"]},{"name":"Division of Nephrology, Department of Medicine, Western University , London, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026102205031364700_bib1","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease","volume":"46","author":"Marx-Sch\u00fctt","year":"2025","journal-title":"Eur Heart J"},{"key":"2026102205031364700_bib2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"2026102205031364700_bib3","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1161\/STROKEAHA.119.025442","article-title":"Does chronic kidney disease predict stroke risk independent of blood pressure?: a systematic review and meta-regression","volume":"50","author":"Kelly","year":"2019","journal-title":"Stroke"},{"key":"2026102205031364700_bib4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/bmj.c4249","article-title":"Low glomerular filtration rate and risk of stroke: meta-analysis","volume":"341","author":"Lee","year":"2010","journal-title":"BMJ (Online)"},{"key":"2026102205031364700_bib5","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/ndt\/gfv009","article-title":"Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis","volume":"30","author":"Masson","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026102205031364700_bib6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/ckj\/sfv136","article-title":"Modulation of stroke risk in chronic kidney disease","volume":"9","author":"Arnold","year":"2016","journal-title":"Clin Kidney J"},{"key":"2026102205031364700_bib7","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1681\/ASN.2012080841","article-title":"Incidence of stroke before and after dialysis initiation in older patients","volume":"24","author":"Murray","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026102205031364700_bib8","author":"U.S. Renal Data System","year":"2009","journal-title":"USRDS 2009 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States"},{"key":"2026102205031364700_bib9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1053\/j.ajkd.2011.07.016","article-title":"Appraising stroke risk in maintenance hemodialysis patients\u202f: a large single-center cohort study","volume":"59","author":"Power","year":"2012"},{"key":"2026102205031364700_bib10","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1111\/cts.13084","article-title":"Consequences of oral antithrombotic use in patients with chronic kidney disease","volume":"14","author":"Laville","year":"2021","journal-title":"Clin Transl Sci"},{"key":"2026102205031364700_bib11","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1161\/STROKEAHA.116.014422","article-title":"Renal function and the risk of stroke and bleeding in patients with atrial fibrillation: an observational cohort study","volume":"47","author":"Bonde","year":"2016","journal-title":"Stroke"},{"key":"2026102205031364700_bib12","article-title":"Canadian stroke best practice recommendations, acute stroke management, acute ischemic stroke treatment","author":"Heart & Stroke Foundation","year":"2015"},{"key":"2026102205031364700_bib13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/ijs.12551","article-title":"Canadian stroke Best practice recommendations\u202f: hyperacute Stroke Care Guidelines, update 2015","volume":"10","author":"Casaubon","year":"2015","journal-title":"Int J Stroke"},{"key":"2026102205031364700_bib14","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","article-title":"Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis","volume":"379","author":"Wardlaw","year":"2012","journal-title":"Lancet"},{"key":"2026102205031364700_bib15","doi-asserted-by":"publisher","first-page":"(7):CD000213","DOI":"10.1002\/14651858.CD000213.pub3","article-title":"Thrombolysis for acute ischaemic stroke (review)","author":"Wardlaw","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102205031364700_bib16","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1161\/STROKEAHA.122.039086","article-title":"Alteplase for stroke with unknown onset time in chronic kidney disease: a pooled analysis of individual participant data","volume":"53","author":"Miwa","year":"2022","journal-title":"Stroke"},{"key":"2026102205031364700_bib17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/svn-2024-003726","article-title":"Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial","volume":"10","author":"Wu","year":"2025","journal-title":"Stroke Vasc Neurol"},{"key":"2026102205031364700_bib18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2215\/CJN.10481110","article-title":"Thrombolysis for acute stroke in hemodialysis: international survey of expert opinion","volume":"6","author":"Palacio","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026102205031364700_bib19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000357155","article-title":"Acute stroke thrombolysis in end-stage renal disease: a national survey of nephrologist opinion","volume":"124","author":"Power","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"2026102205031364700_bib20","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ekir.2018.04.011","article-title":"Inequality in care and differences in outcome following stroke in people with ESRD","volume":"3","author":"Findlay","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2026102205031364700_bib21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/ndt\/gfp619","article-title":"In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke","volume":"25","author":"Agrawal","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2026102205031364700_bib22","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1212\/01.wnl.0000338459.82173.78","article-title":"Renal function and outcome among stroke patients treated with IV thrombolysis","volume":"71","author":"Lyrer","year":"2008","journal-title":"Neurology"},{"key":"2026102205031364700_bib23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000321516","article-title":"Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry","volume":"31","author":"Naganuma","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"2026102205031364700_bib24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000345071","article-title":"Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke","volume":"35","author":"Power","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"2026102205031364700_bib25","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/ene.12311","article-title":"Effects of low estimated glomerular filtration rate on outcomes after stroke: a hospital-based stroke registry in China","volume-title":"Eur J Neurol","author":"Yang","year":"2014"},{"key":"2026102205031364700_bib26","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1161\/STROKEAHA.113.002859","article-title":"Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke","volume":"44","author":"T\u00fct\u00fcnc\u00fc","year":"2013","journal-title":"Stroke"},{"key":"2026102205031364700_bib27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000356348","article-title":"Is renal dysfunction associated with adverse stroke outcome after thrombolytic therapy?","volume":"37","author":"Hsieh","year":"2014","journal-title":"Cerebrovasc Dis"},{"key":"2026102205031364700_bib28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000353296","article-title":"Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction","volume":"70","author":"Chao","year":"2013","journal-title":"Eur Neurol"},{"key":"2026102205031364700_bib29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/MD.0000000000000006","article-title":"Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IV tPA)","volume":"92","author":"Marsh","year":"2013","journal-title":"Medicine"},{"key":"2026102205031364700_bib30","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.clineuro.2013.04.006","article-title":"Intravenous rt-PA in patients with ischaemic stroke and renal dysfunction","volume":"115","author":"Sobolewski","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"2026102205031364700_bib31","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.03.016","article-title":"Outcomes of thrombolytic treatment for acute ischemic stroke in dialysis-dependent patients in the United States","volume":"22","author":"Tariq","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026102205031364700_bib32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000345087","article-title":"Low glomerular filtration rate increases hemorrhagic transformation in acute ischemic stroke","volume":"35","author":"Lee","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"2026102205031364700_bib33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2013.06.030","article-title":"Elevated urea level is associated with poor clinical outcome and increased mortality post intravenous tissue plasminogen activator in stroke patients","volume":"332","author":"Zhang","year":"2013","journal-title":"J Neurol Sci"},{"key":"2026102205031364700_bib34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jns.2015.09.353","article-title":"Chronic kidney disease and intravenous thrombolysis in acute stroke: a systematic review and meta-analysis","volume":"358","author":"Jung","year":"2015","journal-title":"J Neurol Sci"},{"key":"2026102205031364700_bib35","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1161\/CIRCOUTCOMES.114.001144","article-title":"Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke","volume":"7","author":"Ovbiagele","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026102205031364700_bib36","doi-asserted-by":"publisher","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"2026102205031364700_bib37","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1017\/cjn.2025.13","article-title":"Creation and evolution of the Ontario Stroke Registry: protocol and two decades of data from a population-based clinical stroke registry","volume":"52","author":"Yu","year":"2025","journal-title":"Can J Neurol Sci"},{"key":"2026102205031364700_bib38","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"2026102205031364700_bib39","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/01.STR.24.7.1000","article-title":"Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group","volume":"24","author":"Haley","year":"1993","journal-title":"Stroke"},{"key":"2026102205031364700_bib40","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke","volume":"274","author":"Hacke","year":"1995","journal-title":"J Am Med Assoc"},{"key":"2026102205031364700_bib41","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","author":"The National Insitute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","journal-title":"N Engl J Med"},{"key":"2026102205031364700_bib42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1474-4422(08)70044-9","article-title":"Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial","volume":"7","author":"Davis","year":"2008","journal-title":"Lancet Neurol"},{"key":"2026102205031364700_bib43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026102205031364700_bib44","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3(1)","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Working Group","year":"2013","journal-title":"Kidney Int Suppl."},{"key":"2026102205031364700_bib45","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"2026102205031364700_bib46","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.str.19.5.604.","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van\u00a0Swieten","year":"1988","journal-title":"Stroke"},{"key":"2026102205031364700_bib47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","article-title":"Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores","volume":"54","author":"Normand","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2026102205031364700_bib48","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"2026102205031364700_bib49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/aje\/kwy201","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"key":"2026102205031364700_bib50","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2026102205031364700_bib51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"2026102205031364700_bib52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10654-011-9554-9","article-title":"Estimating measures of interaction on an additive scale for preventive exposures","volume":"26","author":"Knol","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"2026102205031364700_bib53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag222\/71561858\/gfag222.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag222\/71561858\/gfag222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:03:20Z","timestamp":1792659800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article\/doi\/10.1093\/ndt\/gfag222\/8859313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":53,"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag222","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"gfag222"}}